首页 > 最新文献

International Journal of Medical Reviews and Case Reports最新文献

英文 中文
Unexplained fractures in an infant, a clue to osteogenesis imperfecta 婴儿出现不明原因骨折,可能是成骨不全
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1683126275
Joana Moscoso, Mariana Dias, Rita Barreira, D. Malveiro
Introduction: Osteogenesis imperfecta (OI) is an autosomal dominant disorder that affects about 6-7/100,000 patients. Case report: We describe a term neonate, with a supervised pregnancy and fetal ultrasonography at 23 weeks with bone dysplasia suspicion. Physical exam revealed axial hypotonia, increased anterior fontanel with distant cranial sutures and small and tapered nose. Skeletal radiography showed hypomineralization and wormian bones of cranial calotte, thin ribs and short and curved femurs. Genetic test revealed heterozygous variant of p.(Gly328Ser) in exon 19 of the COL1A2 gene, of the missense type. By 2 months of age, parents noticed unexplained left lower limb edema, associated with severe pain and crying, and he was diagnosed with aligned fracture of the left femur diaphysis. Discussion: There are several genetic disorders and congenital defect conditions, such as OI, that have been associated with bone fragility and fractures that can be misdiagnosed as child abuse. possible. This case report highlights the importance of valuing infant’s bone fractures, especially if the fracture is unexplained and located in places like long bones of the arms and legs, ribs and small bones of the hands and feet. Conclusion: Clinicians should always look for fragile bones and exclude causes such as OI. Never forget to exclude, as well, child abuse, as part of differential diagnosis.
成骨不全症(Osteogenesis imperfecta, OI)是一种常染色体显性遗传病,约有6 /10万患者。病例报告:我们描述了一个足月新生儿,与监督妊娠和胎儿超声检查在23周骨发育不良的怀疑。体格检查显示中轴张力低下,前囟门增大,颅骨缝合线较远,鼻小而锥形。骨片示低矿化,颅骨呈虫状,肋骨细,股骨短而弯曲。基因检测显示COL1A2基因第19外显子存在p.(Gly328Ser)杂合变异,为错义型。2个月大时,父母注意到无法解释的左下肢水肿,伴有剧烈疼痛和哭闹,并诊断为左股骨骨干排列性骨折。讨论:有几种遗传性疾病和先天性缺陷,如成骨不全,与骨脆性和骨折有关,可能被误诊为儿童虐待。可能的。这个病例报告强调了重视婴儿骨折的重要性,特别是如果骨折是无法解释的,并且位于手臂和腿的长骨,肋骨和手和脚的小骨头等地方。结论:临床医生应始终寻找脆弱的骨骼,并排除原因,如成骨不全。永远不要忘记排除虐待儿童,作为鉴别诊断的一部分。
{"title":"Unexplained fractures in an infant, a clue to osteogenesis imperfecta","authors":"Joana Moscoso, Mariana Dias, Rita Barreira, D. Malveiro","doi":"10.5455/ijmrcr.172-1683126275","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1683126275","url":null,"abstract":"Introduction: Osteogenesis imperfecta (OI) is an autosomal dominant disorder that affects about 6-7/100,000 patients. Case report: We describe a term neonate, with a supervised pregnancy and fetal ultrasonography at 23 weeks with bone dysplasia suspicion. Physical exam revealed axial hypotonia, increased anterior fontanel with distant cranial sutures and small and tapered nose. Skeletal radiography showed hypomineralization and wormian bones of cranial calotte, thin ribs and short and curved femurs. Genetic test revealed heterozygous variant of p.(Gly328Ser) in exon 19 of the COL1A2 gene, of the missense type. By 2 months of age, parents noticed unexplained left lower limb edema, associated with severe pain and crying, and he was diagnosed with aligned fracture of the left femur diaphysis. Discussion: There are several genetic disorders and congenital defect conditions, such as OI, that have been associated with bone fragility and fractures that can be misdiagnosed as child abuse. possible. This case report highlights the importance of valuing infant’s bone fractures, especially if the fracture is unexplained and located in places like long bones of the arms and legs, ribs and small bones of the hands and feet. Conclusion: Clinicians should always look for fragile bones and exclude causes such as OI. Never forget to exclude, as well, child abuse, as part of differential diagnosis.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77202506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising global, regional and national levels burden of cancer: the case of Benin and implications for national development 不断上升的全球、区域和国家癌症负担:贝宁的案例及其对国家发展的影响
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1666252821
Tahsine Bourandi, Yong Chen
Background: Although cancer mortality rates in Africa are higher than in high-income countries, the disease has received little attention in the region. We aimed to highlight the rising cancer burden in the Republic of Benin, trends, characteristics, controversies, and their implications for national development. Methodology: A review of published studies and documents was conducted using keywords including cancer, incidence, mortality, Africa, The Republic of Benin, risk factors, behavioral issues, cultural disparity, psychosocial and ethnic background in Medline, Scopus, Pubmed, and Google. Some of the incidence and mortality figures retrieved from published papers and the GLOBOCAN website were subjected to graphical and frequency analyses. Findings: Breast cancer and lung cancer accounted for approximately 12% and 18% of all new cancer cases and deaths worldwide, respectively. Africa currently has the fourth highest age-standardized cancer mortality rate globally, with Sub-Saharan Africa having the highest incidence rates. Certain factors, such as westernized diet, urbanization, and possibly increased awareness, had been implicated, though their precise contributions had yet to be determined. Conclusion: Cancer will compound The Republic of Benin’s disease burden, increase poverty and gender inequality, and reverse global gains in maternal and neonatal mortality unless urgent action is taken.
背景:尽管非洲的癌症死亡率高于高收入国家,但该疾病在该区域受到的关注很少。我们的目的是强调贝宁共和国不断上升的癌症负担、趋势、特点、争议及其对国家发展的影响。方法:使用Medline、Scopus、Pubmed和Google上的关键词,包括癌症、发病率、死亡率、非洲、贝宁共和国、危险因素、行为问题、文化差异、社会心理和种族背景,对已发表的研究和文献进行了回顾。从发表的论文和GLOBOCAN网站上检索到的一些发病率和死亡率数据进行了图形和频率分析。研究结果:乳腺癌和肺癌分别约占全球所有新发癌症病例和死亡人数的12%和18%。非洲目前的年龄标准化癌症死亡率在全球排名第四,撒哈拉以南非洲的发病率最高。某些因素,如西方化的饮食、城市化和可能的意识的提高,虽然它们的确切作用还有待确定。结论:除非采取紧急行动,否则癌症将加重贝宁共和国的疾病负担,加剧贫困和性别不平等,并扭转全球在孕产妇和新生儿死亡率方面取得的进展。
{"title":"Rising global, regional and national levels burden of cancer: the case of Benin and implications for national development","authors":"Tahsine Bourandi, Yong Chen","doi":"10.5455/ijmrcr.172-1666252821","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1666252821","url":null,"abstract":"Background: Although cancer mortality rates in Africa are higher than in high-income countries, the disease has received little attention in the region. We aimed to highlight the rising cancer burden in the Republic of Benin, trends, characteristics, controversies, and their implications for national development. Methodology: A review of published studies and documents was conducted using keywords including cancer, incidence, mortality, Africa, The Republic of Benin, risk factors, behavioral issues, cultural disparity, psychosocial and ethnic background in Medline, Scopus, Pubmed, and Google. Some of the incidence and mortality figures retrieved from published papers and the GLOBOCAN website were subjected to graphical and frequency analyses. Findings: Breast cancer and lung cancer accounted for approximately 12% and 18% of all new cancer cases and deaths worldwide, respectively. Africa currently has the fourth highest age-standardized cancer mortality rate globally, with Sub-Saharan Africa having the highest incidence rates. Certain factors, such as westernized diet, urbanization, and possibly increased awareness, had been implicated, though their precise contributions had yet to be determined. Conclusion: Cancer will compound The Republic of Benin’s disease burden, increase poverty and gender inequality, and reverse global gains in maternal and neonatal mortality unless urgent action is taken.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79943860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Un hidrocystome du seuil narinaire : présentation atypique à propos d'un cas 鼻孔阈值囊肿:一个病例的非典型表现
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1654530797
Oumaima Boukhlouf, O. Bouanani, R. Azzouzi, M. Boulaadas
L’hidrocystome est une lésion kystique rare, d'étiologie inconnue, présentant 4,2% des tumeurs annexielles cutanées, qui se forme aux dépens des glandes sudoripares eccrines ou apocrines, siégeant préférentiellement au niveau des glandes de la région palpébrale. Nous rapportons le cas d’une localisation atypique de l’histiocytome au niveau du seuil narinaire chez une patiente âgée de 57 ans.
囊性囊肿是一种罕见的囊性病变,病因不明,占皮肤附件肿瘤的4.2%,形成于外胚层汗腺或无胚层汗腺,主要位于眼睑区域的腺体水平。我们报道了一位57岁的患者在鼻孔阈值处组织细胞瘤的非典型位置。
{"title":"Un hidrocystome du seuil narinaire : présentation atypique à propos d'un cas","authors":"Oumaima Boukhlouf, O. Bouanani, R. Azzouzi, M. Boulaadas","doi":"10.5455/ijmrcr.172-1654530797","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1654530797","url":null,"abstract":"L’hidrocystome est une lésion kystique rare, d'étiologie inconnue, présentant 4,2% des tumeurs annexielles cutanées, qui se forme aux dépens des glandes sudoripares eccrines ou apocrines, siégeant préférentiellement au niveau des glandes de la région palpébrale. Nous rapportons le cas d’une localisation atypique de l’histiocytome au niveau du seuil narinaire chez une patiente âgée de 57 ans.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90942596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facial neuritis following after COVID-19 vaccination : Case report and Literature review COVID-19疫苗接种后面神经炎:病例报告及文献复习
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1672202901
Pasut Limchoopornwikul, Yong Wang, X. Liu, Jing Guo
INTRODUCTION: Facial neuritis is a disease of the nervous system, characterized by shallowing or disappearing wrinkles of the frontalis muscle, incomplete eyelid closure, shallowing nasolabial groove, skewing mouth angle, showing teeth to the healthy side, and skewing mouth angle to the affected side when relaxing. CASE REPORT: In this article, it is reported that a 27-year-old male patient was diagnosed as facial neuritis, and the patient appeared after injection of the COVID-19 vaccine (Modena mRNA-1273) on May 17, 2022. After inspection, no obvious abnormality was found on the MRI plain scan of brain. Electromyography: the left and right facial nerve conduction were normal, and the amplitude of evoked potential on the left side was significantly lower than that on the right side. House-Brackmann Facial Nerve grade IV, the patient's condition improved 14 days after hormone treatment. CONCLUSION: The causal relationship between vaccination and the development of Facial neuritis uncertain. The temporal relationship to the vaccination should encourage health care professionals to be vigilant toward people developing Bell’s palsy after SARS-CoV-2 vaccination with mRNA vaccine. Diagnosis and treatment should be swift and decisive.
面神经炎是一种神经系统疾病,表现为额肌皱纹变浅或消失,眼睑闭合不全,鼻唇沟变浅,嘴角角歪斜,牙齿向健侧露出,放松时嘴角角向患侧歪斜。病例报告:本文报告一名27岁男性患者,于2022年5月17日注射新冠病毒疫苗(摩德纳mRNA-1273)后出现面神经炎。经检查,脑MRI平扫未见明显异常。肌电图:左右面神经传导正常,左侧诱发电位幅度明显低于右侧。House-Brackmann面部神经IV级,患者在激素治疗14天后病情好转。结论:疫苗接种与面神经炎发生的因果关系尚不明确。与疫苗接种的时间关系应该鼓励卫生保健专业人员警惕使用mRNA疫苗接种SARS-CoV-2后发生贝尔麻痹的人。诊断和治疗应迅速而果断。
{"title":"Facial neuritis following after COVID-19 vaccination : Case report and Literature review","authors":"Pasut Limchoopornwikul, Yong Wang, X. Liu, Jing Guo","doi":"10.5455/ijmrcr.172-1672202901","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1672202901","url":null,"abstract":"INTRODUCTION: Facial neuritis is a disease of the nervous system, characterized by shallowing or disappearing wrinkles of the frontalis muscle, incomplete eyelid closure, shallowing nasolabial groove, skewing mouth angle, showing teeth to the healthy side, and skewing mouth angle to the affected side when relaxing. CASE REPORT: In this article, it is reported that a 27-year-old male patient was diagnosed as facial neuritis, and the patient appeared after injection of the COVID-19 vaccine (Modena mRNA-1273) on May 17, 2022. After inspection, no obvious abnormality was found on the MRI plain scan of brain. Electromyography: the left and right facial nerve conduction were normal, and the amplitude of evoked potential on the left side was significantly lower than that on the right side. House-Brackmann Facial Nerve grade IV, the patient's condition improved 14 days after hormone treatment. CONCLUSION: The causal relationship between vaccination and the development of Facial neuritis uncertain. The temporal relationship to the vaccination should encourage health care professionals to be vigilant toward people developing Bell’s palsy after SARS-CoV-2 vaccination with mRNA vaccine. Diagnosis and treatment should be swift and decisive.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91196186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short- and Long-term side effects of Concomitant Chemoradiation treatment for Cervical Cancer 宫颈癌同期放化疗的短期和长期副作用
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1676895349
Harihar Tiwari, Subhadra Choubey
Concomitant chemoradiation (CRT) for locally advanced cervical cancer has become an established treatment based on randomised trials. Major concerns, however, remain over the acute and late toxicity and hence the generalisability of the conclusions of these studies. The study period was from October 2020 to May 2022. A total of 126 patients with Stage IIB to IIIB Cervical Cancer were taken for the study from Patna Medical College Hospital, Patna, Bihar with consent from the patients. Most of the patients were of stage IIIB (47.60%) in group A and (54%) in group B. Most of the patients had parity ˃5 (68.30%) in group A and (87.30%) in group B. Most of the patients (58.73%) in group A and (66.66%) in group B completed EBRT within the schedule time of 35 days. Twenty seven (42.85%) patients in group A and twenty three (36.50%) patients in group B had break during EBRT due to toxicity. In conclusion, observation during follow up after 6 months group A patients 74.60% had no evidence of disease and in group B 76.19% had no evidence of disease or no residual disease. In group A 25.40% had residual disease and in group B 24.60% had residual disease.
基于随机试验,同步放化疗(CRT)治疗局部晚期宫颈癌已成为一种成熟的治疗方法。然而,主要的问题仍然是急性和晚期毒性,因此这些研究结论的普遍性。研究时间为2020年10月至2022年5月。经患者同意,从比哈尔邦巴特那的巴特那医学院医院共选取126例IIB至IIIB期宫颈癌患者进行研究。A组以IIIB期患者居多(47.60%),B组以54%(54%)。A组和B组中胎次最多(68.30%),胎次最多(87.30%)。A组和B组中绝大多数(58.73%)和(66.66%)患者在35天的计划时间内完成EBRT。A组27例(42.85%)、B组23例(36.50%)患者在EBRT过程中出现毒性破裂。结论:观察随访6个月后,A组74.60%的患者无疾病证据,B组76.19%的患者无疾病证据或无残留疾病。A组残余病变25.40%,B组残余病变24.60%。
{"title":"Short- and Long-term side effects of Concomitant Chemoradiation treatment for Cervical Cancer","authors":"Harihar Tiwari, Subhadra Choubey","doi":"10.5455/ijmrcr.172-1676895349","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1676895349","url":null,"abstract":"Concomitant chemoradiation (CRT) for locally advanced cervical cancer has become an established treatment based on randomised trials. Major concerns, however, remain over the acute and late toxicity and hence the generalisability of the conclusions of these studies. The study period was from October 2020 to May 2022. A total of 126 patients with Stage IIB to IIIB Cervical Cancer were taken for the study from Patna Medical College Hospital, Patna, Bihar with consent from the patients. Most of the patients were of stage IIIB (47.60%) in group A and (54%) in group B. Most of the patients had parity ˃5 (68.30%) in group A and (87.30%) in group B. Most of the patients (58.73%) in group A and (66.66%) in group B completed EBRT within the schedule time of 35 days. Twenty seven (42.85%) patients in group A and twenty three (36.50%) patients in group B had break during EBRT due to toxicity. In conclusion, observation during follow up after 6 months group A patients 74.60% had no evidence of disease and in group B 76.19% had no evidence of disease or no residual disease. In group A 25.40% had residual disease and in group B 24.60% had residual disease.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91116279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study of efficacy of Escitalopram monotherapy versus combination with L-methyl folate or Mirtazapine in first episode of Depression 艾司西酞普兰单药与l -甲基叶酸或米氮平联合治疗抑郁症首发疗效的比较研究
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1682554614
U. Sardesai, R. Mathur, Ashvina Chouhan, V. Pal, Megha Maholi
Abstract Background: Depression is usually managed in primary care and antidepressants are often the first-line treatment, but only half of those treated respond to a single antidepressant. Objectives: To compare efficacy of Escitalopram monotherapy versus combination with L-methyl folate or Mirtazapine in first episode of Depression Design: The comparative follow-up study was conducted from June 2021 to May 2022 in the Department of Psychiatry, MGM medical college, Indore (M.P.). Setting: Participants were recruited from Psychiatry outpatient department (OPD) in Mental Hospital Indore and MY Hospital, Indore. Participants: The study included 40 patients of age 18-45 years, attending Psychiatry outpatient department (OPD in Mental Hospital Indore and MY Hospital Indore, fulfilling the inclusion criteria. Interventions: Participants were divided into three groups- A, B and C. Group A was given Escitalopram as drug monotherapy, and Group B was given Escitalopram with L-methyl folate 7.5mg and group C was given Escitalopram with Mirtazapine 7.5mg combination therapy. Follow up was done on 2nd and 4th to assess improvement in the symptoms. Results: On comparing HAM scores for R50 (50% reduction in initial HAM score) in each group. In group A, R50 was achieved in 20% patients in the 4th week. In group B, R50 was achieved at 12.5% in the 2nd week, 30% in the 4th week. In group C, R50 was achieved 37.5% in 4th week. The majority of the population in our study belongs to lower socio-economic status and were unemployed resulting in dietary deficiencies hence responded well with L-methyl folate which can cross blood brain barrier. Conclusions: On the basis of available literature and result of the index study, it can be concluded that combination therapies showed better response suggested by HAM scores at the end of study. Moreover, the response achieved with combination therapies were earlier as compared to monotherapy. This substantiate the findings of previous studies. Thus, the study suggest earlier response rates when patients received L-Methylfolate 7.5mg. When compared with monotherapy both the combination therapies achieved earlier and better response.
摘要背景:抑郁症通常在初级保健中进行管理,抗抑郁药物通常是一线治疗,但只有一半的患者对单一抗抑郁药物有效。目的:比较艾司西酞普兰单药治疗与l -甲基叶酸或米氮平联合治疗抑郁症首发的疗效。设计:对比随访研究于2021年6月至2022年5月在印度米高梅医学院精神学系进行。环境:参与者从印多尔精神病院和印多尔MY医院的精神科门诊部(OPD)招募。研究对象:年龄18-45岁,在印多尔精神病院和印多尔MY医院精神病门诊部就诊,符合纳入标准的患者40例。干预措施:将受试者分为A、B、C三组,A组给予艾司西酞普兰单药治疗,B组给予艾司西酞普兰联合l -甲基叶酸7.5mg, C组给予艾司西酞普兰联合米氮平7.5mg联合治疗。在第2日和第4日进行随访以评估症状的改善情况。结果:比较各组R50(初始HAM评分降低50%)的HAM评分。在A组,20%的患者在第4周达到R50。B组第2周R50达到12.5%,第4周R50达到30%。C组第4周R50达到37.5%。在我们的研究中,大多数人属于社会经济地位较低,失业导致饮食不足,因此l -甲基叶酸可以通过血脑屏障。结论:根据现有文献和指标研究结果,可以得出结论,联合治疗在研究结束时HAM评分显示的疗效更好。此外,与单药治疗相比,联合治疗的疗效更早。这证实了以前的研究结果。因此,该研究表明,当患者接受7.5毫克l -甲基叶酸时,反应率较早。与单药治疗相比,两种联合治疗均能获得更早、更好的疗效。
{"title":"Comparative study of efficacy of Escitalopram monotherapy versus combination with L-methyl folate or Mirtazapine in first episode of Depression","authors":"U. Sardesai, R. Mathur, Ashvina Chouhan, V. Pal, Megha Maholi","doi":"10.5455/ijmrcr.172-1682554614","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1682554614","url":null,"abstract":"Abstract Background: Depression is usually managed in primary care and antidepressants are often the first-line treatment, but only half of those treated respond to a single antidepressant. Objectives: To compare efficacy of Escitalopram monotherapy versus combination with L-methyl folate or Mirtazapine in first episode of Depression Design: The comparative follow-up study was conducted from June 2021 to May 2022 in the Department of Psychiatry, MGM medical college, Indore (M.P.). Setting: Participants were recruited from Psychiatry outpatient department (OPD) in Mental Hospital Indore and MY Hospital, Indore. Participants: The study included 40 patients of age 18-45 years, attending Psychiatry outpatient department (OPD in Mental Hospital Indore and MY Hospital Indore, fulfilling the inclusion criteria. Interventions: Participants were divided into three groups- A, B and C. Group A was given Escitalopram as drug monotherapy, and Group B was given Escitalopram with L-methyl folate 7.5mg and group C was given Escitalopram with Mirtazapine 7.5mg combination therapy. Follow up was done on 2nd and 4th to assess improvement in the symptoms. Results: On comparing HAM scores for R50 (50% reduction in initial HAM score) in each group. In group A, R50 was achieved in 20% patients in the 4th week. In group B, R50 was achieved at 12.5% in the 2nd week, 30% in the 4th week. In group C, R50 was achieved 37.5% in 4th week. The majority of the population in our study belongs to lower socio-economic status and were unemployed resulting in dietary deficiencies hence responded well with L-methyl folate which can cross blood brain barrier. Conclusions: On the basis of available literature and result of the index study, it can be concluded that combination therapies showed better response suggested by HAM scores at the end of study. Moreover, the response achieved with combination therapies were earlier as compared to monotherapy. This substantiate the findings of previous studies. Thus, the study suggest earlier response rates when patients received L-Methylfolate 7.5mg. When compared with monotherapy both the combination therapies achieved earlier and better response.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86961228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long term disease control under aromatase inhibitor for advanced low grade stromal endometrial carcinoma: Case Repot from a tertiary care hospital in Morocco. 芳香化酶抑制剂对晚期低级别间质子宫内膜癌的长期疾病控制:来自摩洛哥一家三级医院的病例报告。
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1678098710
M. Ismaili, I. Stitou, O. Siyouri, K. Ismaili, L. Amaadour, K. Oualla, Z. Benbrahim, S. Arifi, N. Mellas
Low-grade stromal endometrial sarcoma (ESS) is a rare type of uterine cancer that arises from the stromal cells of the endometrium, which is the inner lining of the uterus. It is a subtype of endometrial stromal sarcoma, which is a group of tumors that are characterized by the presence of cells that resemble the normal stromal cells of the endometrium. The optimal management of low-grade ESS is not well established, but surgical resection followed by adjuvant hormonal therapy or chemotherapy may be considered depending on the patient's individual characteristics. we report the case of a 66 years old women, diagnosed with a low grade stromal endometrial sarcoma, treated in our tertiary hospital with surgery and endocrine therapy.
低级别子宫内膜间质肉瘤(ESS)是一种罕见的子宫癌,起源于子宫内膜的间质细胞。它是子宫内膜间质肉瘤的一个亚型,子宫内膜间质肉瘤是一组肿瘤,其特征是存在与子宫内膜正常间质细胞相似的细胞。低级别ESS的最佳治疗方法尚未确定,但根据患者的个体特征,可以考虑手术切除后辅助激素治疗或化疗。我们报告一例66岁的女性,诊断为低级别间质子宫内膜肉瘤,在我们的三级医院接受手术和内分泌治疗。
{"title":"Long term disease control under aromatase inhibitor for advanced low grade stromal endometrial carcinoma: Case Repot from a tertiary care hospital in Morocco.","authors":"M. Ismaili, I. Stitou, O. Siyouri, K. Ismaili, L. Amaadour, K. Oualla, Z. Benbrahim, S. Arifi, N. Mellas","doi":"10.5455/ijmrcr.172-1678098710","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1678098710","url":null,"abstract":"Low-grade stromal endometrial sarcoma (ESS) is a rare type of uterine cancer that arises from the stromal cells of the endometrium, which is the inner lining of the uterus. It is a subtype of endometrial stromal sarcoma, which is a group of tumors that are characterized by the presence of cells that resemble the normal stromal cells of the endometrium. The optimal management of low-grade ESS is not well established, but surgical resection followed by adjuvant hormonal therapy or chemotherapy may be considered depending on the patient's individual characteristics. we report the case of a 66 years old women, diagnosed with a low grade stromal endometrial sarcoma, treated in our tertiary hospital with surgery and endocrine therapy.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84701930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence, risk factors, and outcomes of multifetal gestation: A prospective, single center study from Central India 多胎妊娠的发生率、危险因素和结局:一项来自印度中部的前瞻性单中心研究
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1660483279
S. Srivastava, Swati Gupta, Neha Baraithya
Introduction: Multifetal pregnancies (MFPs) are high risk pregnancies and are associated with higher complications and adverse outcomes. Aims and Objectives: To assess the incidence, risk factors, comorbidities, and outcomes of MFPs. Materials and Method: This prospective, observational study was performed over a period of 12 months (December 2018 to November 2019) and involved 212 women with MFP admitted in antenatal ward and labor room of a tertiary care center located in Central India. Maternal characteristics including age, parity, gestational age, mode of delivery, and maternal comorbidities and complications were recorded. Finally, neonatal morbidity and mortality was studied. Results: The incidence of MFP was 1.25%, with that of twin and triplet pregnancy being 1.22% and 0.03%, respectively. Majority of the women belonged to the age group of 25-30 years (43.3%), were multigravida (53.3%), and had a gestational age of 34-36 weeks (41.03%). Women most commonly underwent vaginal delivery (58.01%). The predominantly comorbidity and complications were hypertensive disorders (36.8) and preterm labor (58.49%), respectively. Majority of the neonates had low birth weight (LBW, 80.3%). There was no significant difference between the first and second twin in terms of LBW (P-value >0.05). Perinatal mortality was statistically associated with both prematurity and LBW (both P-values <0.0001). Conclusion: Overall, MFP was associated with high maternal and perinatal morbidity and mortality. Increased parity, low SES, rural area of residence, and advancing maternal age were the major determinants of MFPs. Perinatal mortality was significantly associated with LBW and prematurity.
多胎妊娠(MFPs)是高危妊娠,具有较高的并发症和不良结局。目的和目的:评估mfp的发病率、危险因素、合并症和预后。材料和方法:这项前瞻性观察性研究进行了12个月(2018年12月至2019年11月),涉及印度中部一家三级护理中心产前病房和产房收治的212名MFP妇女。记录产妇的年龄、胎次、胎龄、分娩方式、产妇合并症和并发症。最后,研究了新生儿的发病率和死亡率。结果:MFP发生率为1.25%,双胎和三胞胎妊娠发生率分别为1.22%和0.03%。以25 ~ 30岁(43.3%)、多胎(53.3%)、孕龄34 ~ 36周(41.03%)为主。女性最常见的方式是阴道分娩(58.01%)。主要的合并症和并发症分别是高血压疾病(36.8%)和早产(58.49%)。新生儿以低出生体重为主(LBW占80.3%)。第一胎和第二胎的体重差异无统计学意义(p值>0.05)。围产期死亡率与早产和体重均有统计学相关性(p值均<0.0001)。结论:总体而言,MFP与高产妇和围产期发病率和死亡率有关。胎次增加、低社会经济地位、农村居住地区和产妇年龄增加是mfp的主要决定因素。围产期死亡率与低体重和早产显著相关。
{"title":"Incidence, risk factors, and outcomes of multifetal gestation: A prospective, single center study from Central India","authors":"S. Srivastava, Swati Gupta, Neha Baraithya","doi":"10.5455/ijmrcr.172-1660483279","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1660483279","url":null,"abstract":"Introduction: Multifetal pregnancies (MFPs) are high risk pregnancies and are associated with higher complications and adverse outcomes. Aims and Objectives: To assess the incidence, risk factors, comorbidities, and outcomes of MFPs. Materials and Method: This prospective, observational study was performed over a period of 12 months (December 2018 to November 2019) and involved 212 women with MFP admitted in antenatal ward and labor room of a tertiary care center located in Central India. Maternal characteristics including age, parity, gestational age, mode of delivery, and maternal comorbidities and complications were recorded. Finally, neonatal morbidity and mortality was studied. Results: The incidence of MFP was 1.25%, with that of twin and triplet pregnancy being 1.22% and 0.03%, respectively. Majority of the women belonged to the age group of 25-30 years (43.3%), were multigravida (53.3%), and had a gestational age of 34-36 weeks (41.03%). Women most commonly underwent vaginal delivery (58.01%). The predominantly comorbidity and complications were hypertensive disorders (36.8) and preterm labor (58.49%), respectively. Majority of the neonates had low birth weight (LBW, 80.3%). There was no significant difference between the first and second twin in terms of LBW (P-value >0.05). Perinatal mortality was statistically associated with both prematurity and LBW (both P-values <0.0001). Conclusion: Overall, MFP was associated with high maternal and perinatal morbidity and mortality. Increased parity, low SES, rural area of residence, and advancing maternal age were the major determinants of MFPs. Perinatal mortality was significantly associated with LBW and prematurity.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83857773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report on Lytic Lesion of upper end of the humerus in 32 year old lady 32岁女性肱骨上端溶解性病变1例报告
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1672380353
Dr. Minu Jose Chiramel, Dr. S. N. Waghmare, Dijoe Davis
As a heterogeneous category of malignant neoplasms with a variety of histological characteristics, chondrosarcomas are distinguished by the production of cartilaginous matrix. Oncological surgical excision is the preferred form of treatment due to the disease's inherent resistance to chemotherapy and radiation. Histological grading and tumor localisation localization are the most crucial prognostic indicators having a huge impact on treatment plan. The prognosis for proximal humerus chondrosarcoma has marginally improved, particularly for low and moderate grade tumors. This case reports a 32-year-old female who presented with shoulder pain for the past few days and was diagnosed with grade-2 chondrosarcoma. She was successfully treated with surgical excision of the growing tumor with reconstruction of the humerus.
软骨肉瘤是一种异质性的恶性肿瘤,具有多种组织学特征,其特点是软骨基质的产生。肿瘤手术切除是首选的治疗形式,由于该疾病固有的抵抗化疗和放疗。组织学分级和肿瘤定位是最重要的预后指标,对治疗方案有很大影响。肱骨近端软骨肉瘤的预后略有改善,特别是低度和中度肿瘤。本病例报告一名32岁女性,过去几天出现肩部疼痛,被诊断为2级软骨肉瘤。她成功地通过手术切除生长的肿瘤并重建肱骨。
{"title":"A case report on Lytic Lesion of upper end of the humerus in 32 year old lady","authors":"Dr. Minu Jose Chiramel, Dr. S. N. Waghmare, Dijoe Davis","doi":"10.5455/ijmrcr.172-1672380353","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1672380353","url":null,"abstract":"As a heterogeneous category of malignant neoplasms with a variety of histological characteristics, chondrosarcomas are distinguished by the production of cartilaginous matrix. Oncological surgical excision is the preferred form of treatment due to the disease's inherent resistance to chemotherapy and radiation. Histological grading and tumor localisation localization are the most crucial prognostic indicators having a huge impact on treatment plan. The prognosis for proximal humerus chondrosarcoma has marginally improved, particularly for low and moderate grade tumors. This case reports a 32-year-old female who presented with shoulder pain for the past few days and was diagnosed with grade-2 chondrosarcoma. She was successfully treated with surgical excision of the growing tumor with reconstruction of the humerus.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76599739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed tracheal perforation post total thyroidectomy 甲状腺全切除术后迟发性气管穿孔
Pub Date : 2023-01-01 DOI: 10.5455/ijmrcr.172-1683327531
L. Mendes, Anila Rebecca, Eva Orosova, Cheryl Terrington, G. Galatá, S. Villar
Delayed tracheal perforation is a rare occurrence post thyroidectomy. We present a 72 year-old female patient that underwent elective total thyroidectomy and right upper parathyroidectomy, with bilateral central lymph node dissection and modified radical neck dissection. The post-operative period was complicated by high-risk pre-morbid status and multiple failed extubations, in addition to ischaemic tracheal areas visualised on the bronchoscopy on post-operative day (POD) 8, with subsequent computerised tomography (CT) scan showing anterior neck collections and perforation. A tracheal perforation involving the anterolateral wall (2nd and 3rd rings) was repaired surgically, followed by a tracheostomy. Suspicion of tracheal injuries should always be considered if patient fail to liberate from the mechanical ventilation post-operatively, warranting prompt conservative and/or surgical management. Potential devascularisation, secondary to diathermy-induced injury and pressure exerted by endotracheal tube cuff onto already weakened/friable trachea, should be considered as probable aetiological factors.
迟发性气管穿孔是甲状腺切除术后的罕见现象。我们报告了一位72岁的女性患者,她接受了选择性甲状腺全切除术和右上甲状旁腺切除术,并进行了双侧中央淋巴结清扫和改良根治性颈部清扫。术后的并发症包括高风险的发病前状态和多次拔管失败,以及术后第8天(POD)在支气管镜检查中发现的缺血气管区域,随后的计算机断层扫描(CT)显示前颈部积液和穿孔。气管穿孔累及前外侧壁(第2环和第3环)手术修复,随后气管切开术。如果患者术后不能脱离机械通气,应始终考虑气管损伤的嫌疑,及时采取保守和/或手术治疗。潜在的断流,继发于透热引起的损伤和气管内套管对已经变弱/脆弱的气管施加的压力,应被视为可能的病因因素。
{"title":"Delayed tracheal perforation post total thyroidectomy","authors":"L. Mendes, Anila Rebecca, Eva Orosova, Cheryl Terrington, G. Galatá, S. Villar","doi":"10.5455/ijmrcr.172-1683327531","DOIUrl":"https://doi.org/10.5455/ijmrcr.172-1683327531","url":null,"abstract":"Delayed tracheal perforation is a rare occurrence post thyroidectomy. We present a 72 year-old female patient that underwent elective total thyroidectomy and right upper parathyroidectomy, with bilateral central lymph node dissection and modified radical neck dissection. The post-operative period was complicated by high-risk pre-morbid status and multiple failed extubations, in addition to ischaemic tracheal areas visualised on the bronchoscopy on post-operative day (POD) 8, with subsequent computerised tomography (CT) scan showing anterior neck collections and perforation. A tracheal perforation involving the anterolateral wall (2nd and 3rd rings) was repaired surgically, followed by a tracheostomy. Suspicion of tracheal injuries should always be considered if patient fail to liberate from the mechanical ventilation post-operatively, warranting prompt conservative and/or surgical management. Potential devascularisation, secondary to diathermy-induced injury and pressure exerted by endotracheal tube cuff onto already weakened/friable trachea, should be considered as probable aetiological factors.","PeriodicalId":13694,"journal":{"name":"International Journal of Medical Reviews and Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76945044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Medical Reviews and Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1